Adding some positions

I am adding two positions to the portfolio today: BIOD and RIGL. Both have trial results coming out later this year.

BIOD trades very thinly and it will take me a couple of days to get a full position in place. It has been trading in a narrow $0.35 range for the last 10 weeks or so. I am anticipating/hoping for a breakout as interest drives volume and price ahead of the phase 2 results of its ultra-fast acting insulin, BIOD-123 sometime in Q3. In today at $2.75.

RIGL is awaiting results from the OSKIRA trials of its drug, fostamatinib, in RA. AZ is conducting the trials and expects to release data in Q2. I am in this morning at $7.32.